Status:
COMPLETED
Pediatric Acute and Critical Care COVID-19 Registry of Asia
Lead Sponsor:
KK Women's and Children's Hospital
Collaborating Sponsors:
King Chulalongkorn Memorial Hospital
Ramathibodi Hospital
Conditions:
COVID
Pediatric Disorder
Eligibility:
All Genders
Up to 21 years
Brief Summary
In December 2019, an outbreak of pneumonia of unknown aetiology was first reported in the city of Wuhan, Hubei Province, People's Republic of China. Since then, a novel coronavirus, 2019 novel Coronav...
Detailed Description
A retrospective/prospective outbreak study of all suspect cases admitted to hospital since the beginning of the pandemic (December 2019). Clinical and epidemiological information will be extracted fro...
Eligibility Criteria
Inclusion
- COVID-19 suspected cases (by whatever definition)
- COVID-19 confirmed cases (based on PCR or serum specific IgM and IgG antibody of novel coronavirus; serum specific IgG of novel coronavirus from negative to positive or 4 times higher in convalescence than in acute phase)
- \</=21years of age
Exclusion
- COVID-19 suspected cases should not be SARSCoV-2
Key Trial Info
Start Date :
May 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 9 2023
Estimated Enrollment :
1756 Patients enrolled
Trial Details
Trial ID
NCT04395781
Start Date
May 18 2020
End Date
March 9 2023
Last Update
March 14 2023
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Chongqing Hospital Children's Medical Center
Chongqing, China
2
Zhengzhou Children's hospital
Zhengzhou, China
3
Post Graduate Institute of Medical Education and Research
Chandigarh, India
4
General Hospital H. Adam Malik
Medan, Indonesia